• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国感染艾滋病毒女性的死亡率及死亡原因趋势:一项为期10年的研究。

Trends in mortality and causes of death among women with HIV in the United States: a 10-year study.

作者信息

French Audrey L, Gawel Susan H, Hershow Ronald, Benning Lorie, Hessol Nancy A, Levine Alexandra M, Anastos Kathryn, Augenbraun Michael, Cohen Mardge H

机构信息

CORE Center/Stroger (Cook County) Hospital, Rush University, Chicago, IL 60612, USA.

出版信息

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):399-406. doi: 10.1097/QAI.0b013e3181acb4e5.

DOI:10.1097/QAI.0b013e3181acb4e5
PMID:19487953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2769934/
Abstract

BACKGROUND

To assess trends in mortality and cause of death for women with HIV, we studied deaths over a 10-year period among participants in the Women's Interagency HIV Study, a representative US cohort.

METHODS

Deaths were ascertained by National Death Index Plus match, and causes of death determined by death certificate.

RESULTS

From 1995 through 2004, 710 of 2792 HIV-infected participants died. During this interval, the standardized mortality ratio fell from a high of 24.7 in 1996 to a plateau with a mean of 10.3 from 2001 to 2004. Over the decade, deaths from non-AIDS causes increased and accounted for the majority of deaths by 2001-2004. The most common non-AIDS causes of death were trauma or overdose, liver disease, cardiovascular disease, and malignancy. Independent predictors of mortality besides HIV-associated variables were depressive symptoms and active hepatitis B or C. Women who were overweight or obese were significantly less likely to die of AIDS than women of normal weight.

CONCLUSIONS

In the Women's Interagency HIV Study, the death rate has plateaued in recent years. Although HIV-associated factors predicted AIDS and non-AIDS deaths, other treatable conditions predicted mortality. Further gains in reducing mortality among HIV-infected women may require broader access to therapies for depression, viral hepatitis, and HIV itself.

摘要

背景

为评估感染HIV的女性的死亡率和死因趋势,我们对美国一个具有代表性的队列研究——女性机构间HIV研究的参与者在10年期间的死亡情况进行了研究。

方法

通过与国家死亡指数加强版匹配来确定死亡情况,并根据死亡证明确定死因。

结果

从1995年到2004年,2792名感染HIV的参与者中有710人死亡。在此期间,标准化死亡率从1996年的高位24.7降至2001年至2004年平均为10.3的平稳水平。在这十年间,非艾滋病原因导致的死亡人数增加,到2001 - 2004年占死亡人数的大多数。最常见的非艾滋病死因是创伤或药物过量、肝病、心血管疾病和恶性肿瘤。除了与HIV相关的变量外,死亡率的独立预测因素是抑郁症状以及活动性乙型或丙型肝炎。超重或肥胖的女性死于艾滋病的可能性明显低于体重正常的女性。

结论

在女性机构间HIV研究中,近年来死亡率已趋于平稳。虽然与HIV相关的因素可预测艾滋病和非艾滋病死亡,但其他可治疗的状况也可预测死亡率。要进一步降低感染HIV女性的死亡率,可能需要更广泛地提供针对抑郁症、病毒性肝炎和HIV本身的治疗。

相似文献

1
Trends in mortality and causes of death among women with HIV in the United States: a 10-year study.美国感染艾滋病毒女性的死亡率及死亡原因趋势:一项为期10年的研究。
J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):399-406. doi: 10.1097/QAI.0b013e3181acb4e5.
2
Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.1984年至2003年加拿大艾伯塔省南部HIV感染者的死亡率及死亡原因变化情况
HIV Med. 2005 Mar;6(2):99-106. doi: 10.1111/j.1468-1293.2005.00271.x.
3
Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.联合抗逆转录病毒治疗时代感染人类免疫缺陷病毒的女性的死亡原因
Am J Med. 2002 Aug 1;113(2):91-8. doi: 10.1016/s0002-9343(02)01169-5.
4
Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.多中心艾滋病队列研究和妇女机构间HIV研究参与者的死亡率。
Clin Infect Dis. 2007 Jan 15;44(2):287-94. doi: 10.1086/510488. Epub 2006 Dec 12.
5
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.在接受抗逆转录病毒治疗的第一年及后续年份中,HIV感染患者特定死因风险因素的影响。
Clin Infect Dis. 2014 Jul 15;59(2):287-97. doi: 10.1093/cid/ciu261. Epub 2014 Apr 24.
6
Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.35 岁及以上人类免疫缺陷病毒感染和人类免疫缺陷病毒阴性个体在长期队列研究中同时随访的病因特异性预期寿命,1984-2008 年。
Am J Epidemiol. 2013 Jan 15;177(2):116-25. doi: 10.1093/aje/kws321. Epub 2013 Jan 3.
7
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.高效抗逆转录病毒治疗时代的死亡率:HIV门诊研究中死亡和疾病原因的变化
J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34. doi: 10.1097/01.qai.0000233310.90484.16.
8
Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study.女性机构间HIV研究中接受高效抗逆转录病毒治疗的HIV感染者的体重指数与死亡率之间的关系
PLoS One. 2015 Dec 23;10(12):e0143740. doi: 10.1371/journal.pone.0143740. eCollection 2015.
9
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.高效抗逆转录病毒治疗时代人类免疫缺陷病毒(HIV)感染成人的死因:肝炎和癌症的新作用,艾滋病的持续影响
Int J Epidemiol. 2005 Feb;34(1):121-30. doi: 10.1093/ije/dyh307. Epub 2004 Nov 23.
10
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代城市中感染艾滋病毒及有吸毒风险人群队列中的死亡率
Clin Infect Dis. 2005 Sep 15;41(6):864-72. doi: 10.1086/432883. Epub 2005 Aug 16.

引用本文的文献

1
Right Censoring and Mortality in the Multicenter AIDS Cohort Study and Women's Interagency HIV Study.多中心艾滋病队列研究和妇女机构间HIV研究中的右删失与死亡率
Epidemiology. 2025 Jul 1;36(4):511-519. doi: 10.1097/EDE.0000000000001852. Epub 2025 Mar 24.
2
Provocative Findings From a Transdiagnostic Counseling Intervention to Improve Psychiatric Comorbidity and HIV Care Engagement Among People With HIV: A Pilot Randomized Clinical Trial.一项针对改善 HIV 感染者共病和 HIV 护理参与的跨诊断咨询干预措施的挑衅性发现:一项试点随机临床试验。
J Acquir Immune Defic Syndr. 2024 Sep 1;97(1):68-77. doi: 10.1097/QAI.0000000000003457.
3
PKR-like ER kinase (PERK) Haplotypes Are Associated with Depressive Symptoms in People with HIV.蛋白激酶R样内质网激酶(PERK)单倍型与HIV感染者的抑郁症状相关。
J Neurol Psychol. 2023;10(1). doi: 10.13188/2332-3469.1000049. Epub 2023 Mar 9.
4
Astrocyte Activation is A Potential Mechanism Underlying Depressed Mood and Apathy in People with HIV.星形胶质细胞激活是HIV感染者情绪低落和冷漠背后的一种潜在机制。
J Neurol Psychol. 2022;9(1). doi: 10.13188/2332-3469.1000048. Epub 2022 Dec 26.
5
Structural equation model of intersectional microaggressions, discrimination, resilience, and mental health among black women with hiv.结构性方程模型:艾滋病毒感染的黑人女性中的交叉微侵犯、歧视、适应力和心理健康
Health Psychol. 2023 May;42(5):299-313. doi: 10.1037/hea0001275.
6
Hypertension and one-year risk of all-cause mortality among women with treated HIV in the United States.美国接受治疗的 HIV 女性中高血压与全因死亡率的一年风险。
AIDS. 2023 Mar 15;37(4):679-688. doi: 10.1097/QAD.0000000000003461. Epub 2022 Dec 23.
7
Examining Depression as a Risk Factor for Cardiovascular Disease in People with HIV: A Systematic Review.检查 HIV 感染者中的抑郁作为心血管疾病的风险因素:系统评价。
Ann Behav Med. 2023 Jan 2;57(1):1-25. doi: 10.1093/abm/kaab119.
8
Predictors and Consequences of Prescription Opioid Use in Women Living With and Without HIV: 20-Year Follow-Up.预测女性 HIV 感染者和非感染者处方类阿片类药物使用的因素及其后果:20 年随访研究
J Womens Health (Larchmt). 2022 Aug;31(8):1188-1196. doi: 10.1089/jwh.2021.0231. Epub 2022 Feb 28.
9
Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV.在病毒得到抑制的老年男性艾滋病患者中,血浆炎症生物标志物水平升高与情绪低落及生活质量相关,但在女性艾滋病患者中并非如此。
Brain Behav Immun Health. 2020 Aug 13;7:100121. doi: 10.1016/j.bbih.2020.100121. eCollection 2020 Aug.
10
Oral health-related quality of life and unmet dental needs among women living with HIV.HIV 感染者的口腔健康相关生活质量和未满足的牙科需求。
J Am Dent Assoc. 2020 Jul;151(7):527-535. doi: 10.1016/j.adaj.2020.04.013.

本文引用的文献

1
Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996.1996年高效抗逆转录病毒疗法引入前后美国黑人和白人的艾滋病毒死亡率。
Am J Public Health. 2007 Oct;97(10):1884-92. doi: 10.2105/AJPH.2005.081489. Epub 2007 Aug 29.
2
Association of race and gender with use of antiretroviral therapy among HIV-infected individuals in the Southeastern United States.美国东南部HIV感染者中种族和性别与抗逆转录病毒疗法使用情况的关联
South Med J. 2007 Aug;100(8):775-81. doi: 10.1097/SMJ.0b013e3180f626b4.
3
Differential diffusion of HIV technologies by gender: the case of highly active antiretroviral therapy.艾滋病病毒技术在性别方面的差异传播:以高效抗逆转录病毒疗法为例。
AIDS Patient Care STDS. 2007 Jun;21(6):390-9. doi: 10.1089/apc.2006.0061.
4
Obesity and immune cell counts in women.女性的肥胖与免疫细胞计数
Metabolism. 2007 Jul;56(7):998-1004. doi: 10.1016/j.metabol.2007.03.008.
5
Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.多中心艾滋病队列研究和妇女机构间HIV研究参与者的死亡率。
Clin Infect Dis. 2007 Jan 15;44(2):287-94. doi: 10.1086/510488. Epub 2006 Dec 12.
6
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.高效抗逆转录病毒治疗时代纽约市艾滋病患者的死因
Ann Intern Med. 2006 Sep 19;145(6):397-406. doi: 10.7326/0003-4819-145-6-200609190-00003.
7
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.感染人类免疫缺陷病毒者的肝脏相关死亡:D:A:D研究
Arch Intern Med. 2006;166(15):1632-41. doi: 10.1001/archinte.166.15.1632.
8
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.高效抗逆转录病毒治疗时代的死亡率:HIV门诊研究中死亡和疾病原因的变化
J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34. doi: 10.1097/01.qai.0000233310.90484.16.
9
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.有效的治疗改变了HIV血清转化后特定病因死亡率的分布情况。
AIDS. 2006 Mar 21;20(5):741-9. doi: 10.1097/01.aids.0000216375.99560.a2.
10
Alterations in T-cell subset frequency in peripheral blood in obesity.肥胖状态下外周血中T细胞亚群频率的改变。
Obes Surg. 2005 Nov-Dec;15(10):1463-8. doi: 10.1381/096089205774859308.